Riskpilot← Back to searchSign inGet full accessAndviken Aktiebolag
ABActiveOrg 5562734946Arrendegatan 249Medical specialists activities · NACE 8622Est. 19862 employees
Revenue 2025
SEK 961K
+44% vs 2024
EBITDA margin
2.2%
-61% vs 2024
Equity ratio
8.0%
Financial strength
Net profit 2025
SEK 3K
-92% vs 2024
| Revenue | SEK 961K | +44% |
| EBITDA | SEK 21K | -61% |
| Net profit | SEK 3K | -92% |
| Total assets | SEK 854K | +77% |
| Equity | SEK 69K | +4% |
| Employees | 2 | — |
Legal name
Andviken Aktiebolag
Org number
5562734946
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 mars 1986
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget ska bedriva verksamhet avseende föredrag, medicinska konsultationer, handel med förbands- och sjukhusprodukter. Bolaget ska även bedriva professionell fotografering samt därmed förenlig verksamhet.
Address
Arrendegatan 249
Phone
+4630118330
Email
maria@mariaekblad.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 051 | 704 | 352 | 669 | 961 |
| Staff expenses | — | −216 | −66 | −398 | −604 |
| EBITDA | 360 | 129 | −40 | 54 | 21 |
| Depreciation & amort. | −103 | −118 | −109 | −18 | −18 |
| EBIT | 257 | 11 | −150 | 36 | 3 |
| Net financials | −1 | −1 | 2 | −0 | 0 |
| Profit before tax | 440 | 159 | −114 | 36 | 3 |
| Tax | −98 | −38 | — | — | — |
| Net profit | 342 | 121 | −114 | 36 | 3 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 344 | 852 | 599 | 484 | 854 |
| Equity | 480 | 451 | 30 | 66 | 69 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 680 | 367 | 569 | 418 | 786 |
| Total debt | 680 | 367 | 569 | 418 | 786 |
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
20212025
Equity ratio
8.0%
This company
38.2%
Market median
-79% vs market
20212025
Return on equity
4.3%
This company
18.4%
Market median
-77% vs market
20212025
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20212025
Asset turnover
1.12×
This company
1.12×
Market median
+0% vs market
20212025
Debt / equity
11.47×
This company
0.62×
Market median
-1750% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Andviken Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Susanne Teneberg | Deputy Board Member | 0 companies |
| Erik Krister Ekblad | Board of Directors | 0 companies |
| Maria Ekblad | Chairman | 0 companies |